ArticlebioRxiv : the preprint server for biology2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay.
Quinlin M Hanson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.